Results
|
|
66401.
|
|
|
|
66402.
|
|
|
|
66403.
|
|
|
|
66404.
|
Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins. [electronic resource] by
- Dwojak, M
- Bobrowicz, M
- Bil, J
- Bojarczuk, K
- Pyrzynska, B
- Siernicka, M
- Malenda, A
- Lech-Maranda, E
- Tomczak, W
- Giannopoulos, K
- Golab, J
- Winiarska, M
Producer: 20150916
In:
Blood cancer journal vol. 5
Availability: No items available.
|
|
|
66405.
|
|
|
|
66406.
|
|
|
|
66407.
|
|
|
|
66408.
|
|
|
|
66409.
|
|
|
|
66410.
|
|
|
|
66411.
|
|
|
|
66412.
|
|
|
|
66413.
|
|
|
|
66414.
|
|
|
|
66415.
|
|
|
|
66416.
|
|
|
|
66417.
|
|
|
|
66418.
|
|
|
|
66419.
|
|
|
|
66420.
|
|